Bipolar Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Bipolar clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 137 trials

Recruiting
Not Applicable

Cerebellar Modulation of Cognition in Psychosis

SchizophreniaPsychosisSchizoaffective Disorder+1 more
Mclean Hospital95 enrolled2 locationsNCT06107764
Recruiting
Phase 3

Low Frequency Right Dorsolateral Pre Frontal Cortical Repetitive TMS for Bipolar Depression

Bipolar Depression Depressed Phase
Tyler Kaster80 enrolled2 locationsNCT06986460
Recruiting
Not Applicable

Theta-Burst Stimulation for Bipolar Depression

Bipolar DisorderBipolar DepressionTreatment- Resistant Bipolar Disorder+1 more
Centre for Addiction and Mental Health124 enrolled2 locationsNCT06370988
Recruiting
Not Applicable

Cerebellar Stimulation and Cognitive Control

DepressionParkinson DiseaseSchizophrenia+2 more
Krystal Parker, PhD200 enrolled1 locationNCT03217110
Recruiting

Biomarker Research on Ultra-High-Field MRI Combined With Visual Perception Assessment in the Diagnosis and Treatment Outcomes of Severe Mental Disorders

SchizophreniaMajor Depressive Disorder (MDD)Bipolar Disorder+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University320 enrolled1 locationNCT07479758
Recruiting
Phase 2

A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Bipolar I DisorderBipolar II Disorder
AbbVie195 enrolled22 locationsNCT06696755
Recruiting

NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder

MigraineMajor DepressionBipolar Disorder
National Institute of Mental Health (NIMH)1,260 enrolled1 locationNCT05669703
Recruiting
Not Applicable

Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

Bipolar Disorder and Major Depressive Disorder
CHU de Reims180 enrolled1 locationNCT06740331
Recruiting
Phase 3

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

DepressionBipolar I Disorder
AbbVie380 enrolled78 locationsNCT04777357
Recruiting
Not Applicable

Time and Virtual Reality in Schizophrenia and Bipolar Disorder

SchizophreniaBipolar Disorder
Institut National de la Santé Et de la Recherche Médicale, France120 enrolled1 locationNCT04432116
Recruiting

LHC-CIDI-5 in Hong Kong

Suicidal IdeationObsessive Compulsive Disorder (OCD)Major Depressive Disorder (MDD)+20 more
The University of Hong Kong2,500 enrolled1 locationNCT06804525
Recruiting
Phase 4

Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

ObesityWeight LossBipolar I Disorder+3 more
Mayo Clinic100 enrolled1 locationNCT07213466
Recruiting

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

SchizophreniaSchizoaffective DisorderDelusional Disorder+4 more
Beth Israel Deaconess Medical Center320 enrolled6 locationsNCT06740383
Recruiting

University of Iowa Interventional Psychiatry Service Patient Registry

Major Depressive DisorderMajor DepressionObsessive-Compulsive Disorder+4 more
Mark Niciu1,000 enrolled1 locationNCT04480918
Recruiting
Not Applicable

PROgram To Enhance Cardiovascular Risk Trough an Intervention of Nutrition in Bipolar Disorder

Bipolar DepressionBipolar Disorder (BD)
University of Sao Paulo88 enrolled1 locationNCT06488573
Recruiting

Evaluation of Patients With Mood and Anxiety Disorders and Healthy Volunteers

DepressionHealthy VolunteersAnxiety Disorders+2 more
National Institute of Mental Health (NIMH)16,000 enrolled1 locationNCT00024635
Recruiting
Not Applicable

Enhanced Coordinated Specialty Care for Early Psychosis

SchizophreniaBipolar DisorderPsychosis+2 more
Mclean Hospital350 enrolled5 locationsNCT06071858
Recruiting
Not Applicable

Efficacy, Tolerability, and Cognitive Effects of Deep Transcranial Magnetic Stimulation for Bipolar Depression

Bipolar Depression
Tianjin Anding Hospital100 enrolled1 locationNCT06524505
Recruiting
Phase 4

RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

Unipolar DepressionBipolar Depression
Mayo Clinic120 enrolled1 locationNCT07266545
Recruiting
Phase 3

Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive Episodes of Bipolar Disorder Types I and II.

Bipolar Affective Disorder
University of Sao Paulo40 enrolled1 locationNCT07412132